Antiangiogenic Drugs in NASH: Evidence of a Possible New Therapeutic Approach

Non-alcoholic fatty liver disease is the most common liver disorder worldwide, and its progressive form non-alcoholic steatohepatitis (NASH) is a growing cause of liver cirrhosis and hepatocellular carcinoma (HCC). Lifestyle changes, which are capable of improving the prognosis, are hard to achieve,...

Descripción completa

Detalles Bibliográficos
Autores principales: Orlandi, Paola, Solini, Anna, Banchi, Marta, Brunetto, Maurizia Rossana, Cioni, Dania, Ghiadoni, Lorenzo, Bocci, Guido
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8539163/
https://www.ncbi.nlm.nih.gov/pubmed/34681219
http://dx.doi.org/10.3390/ph14100995

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8539163/
https://www.ncbi.nlm.nih.gov/pubmed/34681219
http://dx.doi.org/10.3390/ph14100995

Ejemplares similares